Delivery Order SPE2DX22D0010-SPE2D825FHG86
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $94,955.58 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $37,266.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,064.80 to AmerisourceBergen Drug Corp on August 2, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999.99M and extends through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a $99,378.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,242.80 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The contract was competitively awarded without set-aside designation, reflecting the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,648.74 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $72,974.58 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHG86Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems nationwide. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This delivery order exemplifies AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts with the Department of Defense. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical supplies, and specialized healthcare commodities to support military healthcare programs worldwide. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements through firm fixed-price arrangements for both small-value transactions and substantial orders, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/30/25 |